Prognostic role of 18F-FDG PET/CT in the postoperative evaluation of differentiated thyroid cancer patients (Articolo in rivista)

Type
Label
  • Prognostic role of 18F-FDG PET/CT in the postoperative evaluation of differentiated thyroid cancer patients (Articolo in rivista) (literal)
Anno
  • 2015-01-01T00:00:00+01:00 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#doi
  • 10.1097/RLU.0000000000000621 (literal)
Alternative label
  • Pace L.; Klain M.; Salvatore B.; Nicolai E.; Zampella E.; Assante R.; Pellegrino T.; Storto G.; Fonti R.; Salvatore M. (2015)
    Prognostic role of 18F-FDG PET/CT in the postoperative evaluation of differentiated thyroid cancer patients
    in Clinical nuclear medicine
    (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
  • Pace L.; Klain M.; Salvatore B.; Nicolai E.; Zampella E.; Assante R.; Pellegrino T.; Storto G.; Fonti R.; Salvatore M. (literal)
Pagina inizio
  • 111 (literal)
Pagina fine
  • 115 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#url
  • http://www.scopus.com/inward/record.url?eid=2-s2.0-84921468312&partnerID=q2rCbXpz (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
  • 40 (literal)
Rivista
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroFascicolo
  • 2 (literal)
Note
  • Scopu (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
  • Dipartimento di Medicina e Chirurgia, Università degli Studi di Salerno, Salerno, Italy; Dipartimento di Scienze Biomediche Avanzate, Università degli Studi di Napoli Federico II, Napoli, Italy; Istituto di Biostrutture e Bioimmagini, CNR, Via Tommaso De Amicis 95, Napoli, 80145, Italy; IRCSS SDN, Napoli, Italy; IRCSS CROB, Rionero in Vulture, Italy (literal)
Titolo
  • Prognostic role of 18F-FDG PET/CT in the postoperative evaluation of differentiated thyroid cancer patients (literal)
Abstract
  • PURPOSE:The aim of this study was to evaluate the role of F-FDG PET/CT performed after surgery but before radioiodine therapy in patients with differentiated thyroid cancer. PROCEDURES:FDG PET/CT was performed off l-thyroxine in 60 newly diagnosed differentiated thyroid cancer patients. Clinical and hematological evaluation as well as high-resolution neck ultrasound were performed. All patients underwent a complete follow-up (range, 6-67 months; mean [SD], 31.7 [20.6] months). The date of recurrence or the most recent office visit was recorded. Progression-free survival (PFS) is the primary end point of this study. Analysis was performed by Cox proportional hazards model. Survival curves were generated using Kaplan-Meier estimates, and the log-rank test was used to assess significance. RESULTS:FDG PET/CT was negative in 63% of patients, 20% had FDG thyroid bed uptake, 5% distant metastases, and 12% lymph node FDG uptake. In patients with positive FDG PET/CT scan (ie, those with distant metastases or lymph node uptake), a higher rate of recurrence was observed (50% vs 6%, P < 0.05). Thyroglobulin, neck ultrasound, stage, and FDG PET/CT correlated with PFS at univariate analysis. At multivariate analysis, only thyroglobulin and FDG PET/CT continued to be predictors of PFS. Patients with a negative FDG PET/CT scan have a better PFS either in the whole group or in those with elevated thyroglobulin level (both >2 ng/mL and >10 ng/mL). CONCLUSIONS:FDG PET/CT was abnormal in 17% of patients. Moreover, FDG PET/CT has an independent prognostic role, with a better PFS in patients with a negative scan. (literal)
Prodotto di
Autore CNR
Insieme di parole chiave

Incoming links:


Autore CNR di
Prodotto
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
Insieme di parole chiave di
data.CNR.it